Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

One cat with low thyroid hormone had growth issues, and another with high thyroid hormone had skin problems; both got better with treatment.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Finasteride doesn't affect hormone levels in normal men.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Follicle Stimulating Hormone is important for fertility.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

New drugs are improving treatment for hormone-related diseases in small pets.